United States · FDA National Drug Code directory
Liothyronine Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 75907-001_284a71c7-5913-ff21-9733-f0cf9fc379c2
- Product NDC
- 75907-001
- Form
- TABLET
- Composition / generic term
- Liothyronine Sodium
- Labeler
- Dr. Reddy's Labratories Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240315
- Source listing expiry
- 20261231
Source-listed ingredients
- LIOTHYRONINE SODIUM — 25 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE, PLASTIC (75907-001-01) · 75907-001-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →